Merck collaborates to examine Keytruda in combination with investigational drug
Merck enters a clinical collaboration agreement with Oncologie to evaluate the combination of investigational drug Bavituximab and Keytruda in cancer patients.
Merck enters a clinical collaboration agreement with Oncologie to evaluate the combination of investigational drug Bavituximab and Keytruda in cancer patients.
Leo Pharma acquires exclusive rights to develop and market brodalumab, a treatment for psoriasis, outside of Europe.